Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IntelGenx Appoints André Godin as President | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

IntelGenx Appoints André Godin as President

Will retain current role as chief financial officer

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oral drug delivery company, IntelGenx, has appointed André Godin to the position of president in addition to his current position as the company’s chief financial officer. 
 
In his newly expanded role, Mr. Godin will have overall responsibility for day-to-day operations, financial reporting and budgeting, as well as managing the company’s relationships and interactions with the investment community. He will continue to report to the company’s chief executive officer, Horst Zerbe.
 
“In the time that I have worked with André as a member of IntelGenx’s senior management team, he has earned both my deep personal admiration and great professional respect,” said Dr. Zerbe. “André’s contributions to IntelGenx have already been immeasurable and he is exceptionally well qualified to take on this expanded role. I look forward to continue working with and support him as we build on IntelGenx’s success.”
 
Mr. Godin most recently served as IntelGenx’s executive vice president and chief financial officer. Before joining IntelGenx in 2015, he was interim CEO and CFO of Neptune Technologies and Bioresources.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics